Hyperthermic intraperitoneal chemotherapy enhances antitumor effects on ovarian cancer through immune-mediated cancer stem cell targeting

Hyperthermic intraperitoneal chemotherapy enhances antitumor effects on ovarian cancer through immune-mediated cancer stem cell targeting

Purpose We aimed to determine the effects and possible mechanisms of hyperthermic intraperitoneal chemotherapy (HIPEC) in targeting ovarian cancer stem-like cells (CSCs). Methods Murine ovarian cancer cell lines presenting CSC surface markers were grown intraperitoneally in both immunocompetent and...

Full description

Bibliographic Details
Main Authors:	Chao-Chih Wu, Yun-Ting Hsu, Chih-Long Chang
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2021-01-01
Series:	International Journal of Hyperthermia
Subjects:	hyperthermia hipec ((hyperthermic intraperitoneal chemotherapy) macrophage cancer stem-like cells anti-tumor immunity ovarian cancer
Online Access:	http://dx.doi.org/10.1080/02656736.2021.1945688

Similar Items

Hyperthermic intraperitoneal chemotherapy for recurrent epithelial ovarian cancer
by: Wei-Chun Chen, et al.
Published: (2022-10-01)

Hyperthermic Intraperitoneal Chemotherapy (HIPEC): An Overview of the Molecular and Cellular Mechanisms of Actions and Effects on Epithelial Ovarian Cancers
by: Pei-Qi Lim, et al.
Published: (2022-09-01)

Peritoneal Fluid Analysis of Advanced Ovarian Cancers after Hyperthermic Intraperitoneal Chemotherapy
by: Wei-Chun Chen, et al.
Published: (2023-06-01)

Mechanistic Insights on Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
by: Olivia G. Huffman, et al.
Published: (2023-02-01)

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for ovarian cancer in an Australian institution: lessons from 20 years’ experience
by: R. Farrell, et al.
Published: (2022-09-01)

Hyperthermic intraperitoneal chemotherapy as consolidation treatment of advanced stage ovarian cancer
by: Jieun Ko, et al.
Published: (2021-09-01)

Reply: Serum CA-125 and renal impairment in patients undergoing hyperthermic intraperitoneal chemotherapy
by: Wei-Chun Chen, et al.
Published: (2022-10-01)

The prognosis impact of hyperthermic intraperitoneal chemotherapy (HIPEC) plus cytoreductive surgery (CRS) in advanced ovarian cancer: the meta-analysis
by: Guyu Zhang, et al.
Published: (2019-04-01)

Effect of hyperthermia on improving neutrophil restoration after intraperitoneal chemotherapy
by: Wan-Chun Huang, et al.
Published: (2019-01-01)

Comparative Survival Outcomes of Hyperthermic Intraperitoneal Chemotherapy, Intraperitoneal Chemotherapy and Intravenous Chemotherapy for Primary Advanced Ovarian Cancer: A Network Meta-Analysis
by: Qin Tang, et al.
Published: (2023-01-01)

A novel method of bedside hyperthermic intraperitoneal chemotherapy as adjuvant therapy for stage-III gastric cancer
by: Lili Liu, et al.
Published: (2022-12-01)

Calculating the dose of cisplatin that is actually utilized in hyperthermic intraperitoneal chemotherapy among ovarian cancer patients
by: Wu-yun Wang, et al.
Published: (2021-01-01)

Investigation of the effectiveness of hyperthermic intraperitoneal chemotherapy in experimental colorectal peritoneal metastasis model
by: Manoğlu Berke, et al.
Published: (2023-05-01)

Prophylactic Hyperthermic Intraperitoneal Chemotherapy for Patients at High Risk of Developing Gallbladder Cancer Peritoneal Metastases: Case Report and Rationale for a Prospective Clinical Trial
by: Alexander E. Crum, et al.
Published: (2024-01-01)

Interval debulking surgery with or without hyperthermic intraperitoneal chemotherapy in advanced-stage ovarian cancer: Single-institution cohort study
by: Yong Jae Lee, et al.
Published: (2022-07-01)

Feasibility and safety of neoadjuvant laparoscopic hyperthermic intraperitoneal chemotherapy in patients with advanced stage ovarian cancer: a single-center experience
by: Gao T, et al.
Published: (2019-07-01)

Elevated temperatures and longer durations improve the efficacy of oxaliplatin- and mitomycin C-based hyperthermic intraperitoneal chemotherapy in a confirmed rat model for peritoneal metastasis of colorectal cancer origin
by: Roxan F. C. P. A. Helderman, et al.
Published: (2023-03-01)

A Four-Inflow Construction to Ensure Thermal Stability and Uniformity during Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Rats
by: Daan R. Löke, et al.
Published: (2020-11-01)

Effectiveness of Hyperthermic Intraperitoneal Chemotherapy Associated with Cytoreductive Surgery in the Treatment of Advanced Ovarian Cancer: Systematic Review and Meta-Analysis
by: Maria Llueca, et al.
Published: (2023-01-01)

Hyperthermic intrathoracic/intraperitoneal chemotherapy versus conventional intrapleural/intraperitoneal chemotherapy for the malignant effusion: a multi-center randomized clinical trial
by: Lili Liu, et al.
Published: (2023-12-01)

Assessment of travel distance for hyperthermic intraperitoneal chemotherapy in women with ovarian cancer
by: Laura M. Chambers, et al.
Published: (2022-04-01)

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases: A Summary of Key Clinical Trials
by: Kevin M. Turner, et al.
Published: (2022-06-01)

Race and Ethnicity Impacts Overall Survival of Patients with Appendiceal Cancer Who Undergo Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy
by: Devon C. Freudenberger, et al.
Published: (2023-08-01)

Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
by: McKayla J. Riggs, et al.
Published: (2020-01-01)

Lobaplatin in Prophylactic Hyperthermic Intraperitoneal Chemotherapy for Advanced Gastric Cancer: Safety and Efficacy Profiles
by: Zhong Y, et al.
Published: (2020-06-01)

Data on the quality of life after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal malignancies: does it concern patients with gastric cancer?
by: Skierucha Malgorzata, et al.
Published: (2017-12-01)

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy versus palliative systemic chemotherapy in stomach cancer patients with peritoneal dissemination, the study protocol of a multicentre randomised controlled trial (PERISCOPE II)
by: W. J. Koemans, et al.
Published: (2019-05-01)

Mininvasive Cytoreduction Surgery plus HIPEC for Epithelial Ovarian Cancer: A Systematic Review
by: Carlo Ronsini, et al.
Published: (2023-02-01)

Efficacy of hyperthermic intraperitoneal chemotherapy in patients with epithelial ovarian cancer: a meta-analysis
by: Qiwen Wu, et al.
Published: (2019-01-01)

Acute kidney injury after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with advanced ovarian cancer
by: Yun Bai, et al.
Published: (2023-01-01)

The Role of Hyperthermic Intraperitoneal Chemotherapy in Uterine Cancer Therapy
by: Iason Psilopatis, et al.
Published: (2023-08-01)

Multicystic peritoneal mesothelioma treated with cytoreductive surgery followed or not by hyperthermic intraperitoneal chemotherapy: results from a large multicentric cohort
by: Vahan Kepenekian, et al.
Published: (2021-01-01)

Heated Intraperitoneal Chemotherapy in the Management of Advanced Ovarian Cancer
by: Andrea Jewell, et al.
Published: (2018-09-01)

Side-effects of hyperthermic intraperitoneal chemotherapy in patients with gastrointestinal cancers
by: Jiyun Hu, et al.
Published: (2023-04-01)

Genetic alterations in peritoneal metastatic tumors predicted the outcomes for hyperthermic intraperitoneal chemotherapy
by: Quynh-Anh Nguyen, et al.
Published: (2023-04-01)

Role of intraperitoneal chemotherapy in gastric cancer
by: Amir Parray, et al.
Published: (2021-03-01)

The Temperature-Dependent Effectiveness of Platinum-Based Drugs Mitomycin-C and 5-FU during Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Colorectal Cancer Cell Lines
by: Roxan F.C.P.A. Helderman, et al.
Published: (2020-07-01)

Association between pelvic exenteration and hyperthermic intraperitoneal chemotherapy for rectal cancer
by: Nicolae Bacalbasa, et al.
Published: (2021-06-01)

Single versus multiple hyperthermic intraperitoneal chemotherapy applications for T4 gastric cancer patients: Efficacy and safety profiles
by: Jing Zhang, et al.
Published: (2023-03-01)

Peritoneal metastases from rare ovarian cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC)
by: Falla-Zuniga Luis Felipe, et al.
Published: (2023-12-01)